Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn.

Infants with severe HDFN have increased risk for cholestasis, particularly those requiring multiple intrauterine transfusions. Early and repeated screening for conjugated hyperbilirubinemia in the first week of life is needed to ensure adequate management.